News Releases

News Releases

Apr 29, 2021
NEEDHAM, Mass. , April 29, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, today announced that it will host a live conference call and audio webcast on Thursday, May 6, 2021 at 5:00 pm Eastern Time to discuss financial results for the quarter
Feb 25, 2021
Company to host conference call and webcast at 5:00 p.m. ET NEEDHAM , MA , Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, today announced that it will host a conference call and live audio webcast on Thursday, March 4, 2021 at 5:00
Jan 19, 2021
Appointment provides extensive commercial-stage public company financial leadership experience NEEDHAM, Mass. , Jan. 19, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral
Jan 06, 2021
MYCAPSSA ® launch in US continuing to gain traction with physicians, patients, and payers MYCAPSSA ®   EMA submission for EU marketing approval on track for mid-2021 following positive results of MPOWERED Phase 3 clinical trial NEEDHAM, Mass. , Jan. 06, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc.

This section of our website may contain dated or archived information which should not be considered current and may no longer be accurate. For current information, you are encouraged to review our most recent filings with the U.S. Securities and Exchange Commission.

Shareholder Tools